QIAGEN N.V. (QGEN) › Cash & EquivalentsQIAGEN N.V. (QGEN) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2007: $347.32M2008: $333.31M2009: $825.56M2010: $828.41M2011: $221.13M2012: $394.04M2013: $330.30M2014: $392.67M2015: $290.01M2016: $439.18M2017: $657.71M2018: $1.16B2019: $623.65M2020: $597.98M2021: $880.52M2022: $730.67M2023: $668.08M2024: $663.55M2025: $839.00M$839.00M2007Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$839.00M+26.4%2024$663.55M-0.7%2023$668.08M-8.6%2022$730.67M-17.0%2021$880.52M+47.2%2020$597.98M-4.1%2019$623.65M-46.2%2018$1.16B+76.2%2017$657.71M+49.8%2016$439.18M+51.4%2015$290.01M-26.1%2014$392.67M+18.9%2013$330.30M-16.2%2012$394.04M+78.2%2011$221.13M-73.3%2010$828.41M+0.3%2009$825.56M+147.7%2008$333.31M-4.0%2007$347.32M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share